EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular characterization of colistin resistance in carbapenem-resistant Klebsiella pneumoniae from a tertiary hospital in China

Saiqi Qi iD, Haijun Li, Jilei Ma, Cailin Liu, Nan Yi, Shijun Sun iD, Wanhai Wang iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.01049-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Saiqi Qi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Colistin, Klebsiella pneumoniae, Anti-Bacterial Agents, Klebsiella Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Provincial Science and Technology Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colistin resistance in carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a significant global health challenge, as colistin remains the last-resort antibiotic for treating multidrug-resistant K. pneumoniae infections. This study aimed to investigate the prevalence and molecular mechanisms underlying colistin resistance in CRKP (Col r -CRKP) isolates in Henan, China, from 2021 to 2024. The minimum inhibitory concentrations of colistin for 134 K . pneumoniae isolates were determined using the broth microdilution method. Whole-genome sequencing was performed using the Illumina platform to identify carbapenemase genes and sequence types (STs). Colistin resistance mechanisms were investigated, including mutations in two-component systems ( pmrA / pmrB , phoP / phoQ ), inactivation of the mgrB gene, and the presence of plasmid-mediated mcr genes. Most isolates were collected from intensive care units (99/134, 73.9%), with 48.5% (59/134) of patients having no documented colistin exposure history. Notably, ST11 was the predominant sequence type among Col r -CRKP isolates (113/134, 84.3%), all of which carried bla KPC-2 as the sole carbapenemase determinant. In contrast, seven non-carbapenemase-producing isolates exhibited phenotypic resistance to carbapenems. Genomic analysis revealed inactivation or loss of the mgrB gene in 53.7% (72/134) of isolates, predominantly due to insertion mutations (54/72). Although 32.8% (44/134) of isolates carried mutations in two-component systems, these alterations did not exhibit pathway-specific clustering. Intriguingly, plasmid-mediated mcr genes were detected in only 1.5% (2/134) of cases ( mcr-8.2 and mcr-1.1 ), while 22.4% (30/134) of colistin-resistant strains lacked identifiable resistance determinants based on current detection methods. Our findings indicate that disruption of the mgrB gene is the primary mechanism of colistin resistance in ST11 CRKP clones. The emergence of resistance in 48.5% of patients without prior colistin exposure, combined with low mcr gene prevalence (1.5%) and unexplained resistance in 22.4% of isolates, suggests complex selective pressures beyond direct antimicrobial use. These findings underscore the urgent need for strengthened antimicrobial stewardship and the development of alternative therapeutic strategies to combat this high-risk pathogen. IMPORTANCE The global rise of colistin-resistant Klebsiella pneumoniae , particularly in carbapenem-resistant Klebsiella pneumoniae (CRKP) strains, has severely restricted treatment options for multidrug-resistant infections. Our study provides the first comprehensive molecular characterization of colistin resistance in CRKP in a large tertiary hospital in central China. We identified mgrB disruption as the predominant resistance mechanism, while plasmid-mediated mcr genes were rare. Notably, nearly half of the resistant isolates occurred in patients without prior colistin exposure, suggesting alternative selective pressures driving resistance. These findings highlight the complex dynamics of colistin resistance in CRKP and underscore the need for enhanced genomic surveillance and stewardship interventions to limit further dissemination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColistinKlebsiella pneumoniaeAnti-Bacterial AgentsKlebsiella InfectionsCarbapenemsCarbapenem-Resistant EnterobacteriaceaeDrug Resistance, BacterialHumansChinaMicrobial Sensitivity TestsBacterial ProteinsTertiary Care Centersbeta-LactamasesWhole Genome SequencingPlasmidsDrug Resistance, Multiple, BacterialMutationMale

Stichwörter der Autor:innen

carbapenem-resistant Klebsiella pneumoniae (CRKP)colistin resistanceinsertion sequencemcr/TCS genemgrB

Substanzen

ColistinAnti-Bacterial AgentsBacterial ProteinsCarbapenemscarbapenemasebeta-Lactamases

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Key Clinical Laboratory of Henan Province, Zhengzhou, China.

ORCID-Profile: Saiqi Qi, Shijun Sun, Wanhai Wang

Förderung

  • Henan Provincial Science and Technology Research Project

Zitieren

APA

Qi, S., Li, H., Ma, J., Liu, C., Yi, N., Sun, S., & Wang, W. (2025). Molecular characterization of colistin resistance in carbapenem-resistant Klebsiella pneumoniae from a tertiary hospital in China. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01049-25

Vancouver

Qi S, Li H, Ma J, Liu C, Yi N, Sun S, et al. Molecular characterization of colistin resistance in carbapenem-resistant Klebsiella pneumoniae from a tertiary hospital in China. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01049-25

BibTeX
@article{Qi2025,
  author = {Qi, Saiqi and Li, Haijun and Ma, Jilei and Liu, Cailin and Yi, Nan and Sun, Shijun and Wang, Wanhai},
  title = {Molecular characterization of colistin resistance in carbapenem-resistant Klebsiella pneumoniae from a tertiary hospital in China},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.01049-25}
}
Kostenlos starten →